You are here: Industry Insights > Cancer

News List

Evelo Announces Patent Covering Use of Proprietary Bifidobacterium animalis ssp. lactis Strain americanpharmaceuticalreview
March 06, 2020
Evelo Biosciences announced the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,576,111, entitled “Method of treating cancer using Bifidobacterium animalis ssp.
Harbour BioMed gets FDA nod to begin clinical trial for HBM4003 in cancer pharmaceutical-business-review
March 06, 2020
Harbour BioMed has secured approval from the US Food and Drug Administration (FDA) to move ahead with clinical studies in the US for its anti-CTLA-4 antibody HBM4003 for the treatment of cancer.
Innovations in CAR-T therapies in APAC will make market more competitive, report highlights europeanpharmaceuticalreview
March 05, 2020
Research has shown that the CAR-T therapies in development in Asia-Pacific will make the worldwide market more competitive and drive down prices.
Coronary Artery Disease Risk Down in Survivors of Childhood Cancer drugs
January 20, 2020
There has been a decrease in the risk for coronary artery disease among adult survivors of childhood cancer, according to a study published online January in The BMJ.
Mortality Risk in Oropharynx Cancer Varies Based on HPV Status drugs
January 20, 2020
For patients with oropharynx cancer, the rates of head and neck cancer (HNC) mortality and competing mortality vary depending on human papillomavirus (HPV) status, with increased risks for HNC mortality and competing mortality in HPV-negative patients ...
Colorectal Cancer Risk Still Up in Patients With Ulcerative Colitis drugs
January 19, 2020
Patients with ulcerative colitis have an increased risk for colorectal cancer and colorectal cancer mortality, according to a study published in the January issue of The Lancet.
B cells linked to effective cancer immunotherapy worldpharmanews
January 19, 2020
Cancer patients responded better to immunotherapy and had a better prognosis if their melanoma tumours contained specific clusters of B cells, according to new research from Lund University in Sweden.
NICE recommends olaparib tablets for platinum-sensitive cancer patients europeanpharmaceuticalreview
January 19, 2020
NICE has recommended olaparib tablets (Lynparza, AstraZeneca) for adults with relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancer with a BRCA1 or BRCA2 mutation.
SOTIO Opens Office in Basel, Switzerland, to Accelerate Development of its Pipeline Products b3cnewswire
January 17, 2020
SOTIO, a biotechnology company owned by the PPF Group, announce the opening of offices of SOTIO Biotech AG at the Technology Park Basel, Switzerland.
Increasing Vegetable Intake Does Not Slow Prostate Cancer drugs
January 17, 2020
A behavioral intervention that increases vegetable consumption does not reduce the risk for progression of early-stage prostate cancer, according to a study published in the January issue of the Journal of the American Medical Association.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page